Clinical trial / 1989
A gastric bubble device offered no additional weight loss compared with sham insertion when added to a standard weight loss program in obese patients.
Fifty-nine obese patients were randomized to receive either an endoscopically placed Garren-Edwards gastric bubble (GEGB; 34 patients) or a sham insertion (25 patients). Both groups participated in a standard weight loss program including dietary therapy, behavior modification, and exercise, with bubble removal at 3 months and follow-up for an additional 9 months. Weight loss was the same in both groups at 3 months (18.7 lb vs. 17.2 lb), across measures of pounds, percentage of body weight, and body mass index. The authors concluded that the GEGB provided no added benefit over sham insertion.
- Study type
- Double-blind, randomized, sham-controlled trial
- Who was studied
- 59 obese patients
- What was measured
- Weight loss (change in pounds, percentage of body weight, or body mass index)
THE PAPER
A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity.
Hogan RB, Johnston JH, Long BW, Sones JQ, Hinton LA, Bunge J, Corrigan SA. Gastrointest Endosc, 1989.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.